Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study
BJUI Compass2024Vol. 5(12), pp. 1314–1323
Citations Over TimeTop 18% of 2024 papers
Arjun Nathan, Chuanyu Gao, Alexander Light, Cameron E. Alexander, Vinson Wai‐Shun Chan, Kevin Gallagher, Sinan Khadhouri, Kevin G. Byrnes, Michael Ng, Michael A. Walters, Terry Lynn Hughes, Rita Perry, Kelvin Okoth, Laura Magill, Thomas Pinkney, Yuhao Zhang, James P. Blackmur, Eric Etchill, Stanley Tang, D García Escudero, Alan McNeill, Krishna Narahari, Grant D. Stewart, Veeru Kasivisvanathan, COVIDSurg Collaborative
Abstract
High-risk men were prioritised for surgery during the COVID-19 pandemic. Our prospective data support previous retrospective, cancer-registry evidence suggesting no adverse oncological impact after delaying RP across all risk groups. Our study is limited by the short follow-up period, and therefore, longer term conclusions cannot be drawn.
Related Papers
- → DEFINING PROSTATE SPECIFIC ANTIGEN PROGRESSION AFTER RADICAL PROSTATECTOMY: WHAT IS THE MOST APPROPRIATE CUT POINT?(2001)408 cited
- → Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?(2009)38 cited
- → Understanding differences between high and low volume hospitals for radical prostatectomy(2007)15 cited
- → The Initial Case Report: Salvage Robotic Assisted Radical Prostatectomy After Heavy Ion Radiotherapy(2016)5 cited
- → Initial Therapy With Radical Prostatectomy for High Risk Localized Prostate Cancer(2006)13 cited